中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2012年
11期
1603-1604
,共2页
陈纪海%顾农%张国静%谢非%李加法%袁秋生
陳紀海%顧農%張國靜%謝非%李加法%袁鞦生
진기해%고농%장국정%사비%리가법%원추생
前列腺炎%特拉唑嗪%前列癃闭通胶囊
前列腺炎%特拉唑嗪%前列癃閉通膠囊
전렬선염%특랍서진%전렬륭폐통효낭
Prostatitis%Terazosin%Qianlielongbitong
目的 观察特拉唑嗪联合前列癃闭通胶囊治疗慢性非细菌性前列腺炎(NBP)的疗效.方法 102例NBP患者随机分为治疗组54例和对照组48例,治疗组口服特拉唑嗪+前列癃闭通胶囊;对照组口服特拉唑嗪+左氧氟沙星.分别观察治疗前、治疗4周、8周后慢性前列腺炎症状指数评分(NIH-CPSI)、前列腺按摩液(EPS)常规检查及尿流率的变化.结果 治疗4周后,两组NIH-CPS总评分、症状评分、生活质量评分、疼痛症状评分及排尿症状评分较治疗前均明显改善(t=14.80、16.20、6.15、8.67、10.00、16.47、14.62、8.79、10.77、10.86,均P<0.01);治疗8周后,对照组NIH-CPS评分较治疗4周时无明显改善(均P>0.05),治疗组较治疗4周时有明显改善(t=2.76、2.71、2.75、2.72、2.73,均P<0.01).治疗4周后,两组AFR、MFR较治疗前均增加(t=11.56、11.84、13.85、12.80,均P<0.01);但两组间差异均无统计学意义(均P>0.05).结论 特拉唑嗪联合前列癃闭通胶囊治疗NBP可减轻临床症状,提高生活质量.
目的 觀察特拉唑嗪聯閤前列癃閉通膠囊治療慢性非細菌性前列腺炎(NBP)的療效.方法 102例NBP患者隨機分為治療組54例和對照組48例,治療組口服特拉唑嗪+前列癃閉通膠囊;對照組口服特拉唑嗪+左氧氟沙星.分彆觀察治療前、治療4週、8週後慢性前列腺炎癥狀指數評分(NIH-CPSI)、前列腺按摩液(EPS)常規檢查及尿流率的變化.結果 治療4週後,兩組NIH-CPS總評分、癥狀評分、生活質量評分、疼痛癥狀評分及排尿癥狀評分較治療前均明顯改善(t=14.80、16.20、6.15、8.67、10.00、16.47、14.62、8.79、10.77、10.86,均P<0.01);治療8週後,對照組NIH-CPS評分較治療4週時無明顯改善(均P>0.05),治療組較治療4週時有明顯改善(t=2.76、2.71、2.75、2.72、2.73,均P<0.01).治療4週後,兩組AFR、MFR較治療前均增加(t=11.56、11.84、13.85、12.80,均P<0.01);但兩組間差異均無統計學意義(均P>0.05).結論 特拉唑嗪聯閤前列癃閉通膠囊治療NBP可減輕臨床癥狀,提高生活質量.
목적 관찰특랍서진연합전렬륭폐통효낭치료만성비세균성전렬선염(NBP)적료효.방법 102례NBP환자수궤분위치료조54례화대조조48례,치료조구복특랍서진+전렬륭폐통효낭;대조조구복특랍서진+좌양불사성.분별관찰치료전、치료4주、8주후만성전렬선염증상지수평분(NIH-CPSI)、전렬선안마액(EPS)상규검사급뇨류솔적변화.결과 치료4주후,량조NIH-CPS총평분、증상평분、생활질량평분、동통증상평분급배뇨증상평분교치료전균명현개선(t=14.80、16.20、6.15、8.67、10.00、16.47、14.62、8.79、10.77、10.86,균P<0.01);치료8주후,대조조NIH-CPS평분교치료4주시무명현개선(균P>0.05),치료조교치료4주시유명현개선(t=2.76、2.71、2.75、2.72、2.73,균P<0.01).치료4주후,량조AFR、MFR교치료전균증가(t=11.56、11.84、13.85、12.80,균P<0.01);단량조간차이균무통계학의의(균P>0.05).결론 특랍서진연합전렬륭폐통효낭치료NBP가감경림상증상,제고생활질량.
Objective To investigate the effect and mechanism of terazosin combined with Qianlielongbitong in the treatment of non-bacterial prostatitis.Methods One hundred and two patients with non-bacterial prostatitis were divided into two groups:one group was treated with terazosin 4 mg qn and Qianlielongbitong,while the other group was treated with terazosin and Levoofloxacin.We compared three indices of chronic prostatitis symptom index (NIH-CPSI),prostatic secretion examination(EPS) and urodynamic data in three different steps:before treatment,after 4-week treatment and after 8-week treatment.Results The NIH-CPSI of both groups was greatly improved after treatment( all P <0.01 ).Inside the treatment group,the NIH-C-PSI after 8-week treatment was better than that after 4- week treatment ( all P < 0.01 ).However,in both groups,there was no significant difference between the index after 8-week treatment and the one after 4 week.EPS,AFR and MFR were greatly improved in both groups( all P <0.01 ).Conclusion Terazosin can relieve the clinical symptom,and improve the life quality.